NVI calls for consolidation of research for dengue vaccine

[webfact]

NVI calls for consolidation of research for dengue vaccine

BANGKOK, 22 February 2016 (NNT) – The National Vaccine Institute (NVI) has urged the government to support Thai researchers in developing a dengue fever vaccine after one was created in Mexico.

NVI Director Dr. Jarung Muangchana, disclosed that a private company in Mexico has produced the world’s first vaccine for dengue fever, dubbed Dengvaxia. The solution has already been introduced to the market despite not completely preventing against the illness, only reducing its severity. Dr. Jarung noted that Thailand is also researching the disease and that finding a vaccine against it is a national policy.

The director has urged the government to consolidate efforts by Mahidol University, Chiang Mai University, Chulalongkorn University and various agencies to expedite the search for a vaccine. NVI has formed a working team to review all related aspects of the disease and its treatment, such as costs related to those affected, efficiency of preventative measures and the likelihood of administering vaccinations.

The preliminary vaccination created by Mexico has yet to enter the Thai market as it is being reviewed by the Food and Drug Administration. NVI predicts that its review will take longer than usual due to the solution’s rudimentary status.

-- NNT 2016-02-22

[khunianb]

The vaccine in Mexico was developed by SanofiPasteur. This company has also been working in Thailand with many doctors.

[NCC1701A]

From the Nation:

"The National Vaccine Institute (NVI) has urged the government to support Thai researchers in developing a dengue fever vaccine after one was created in Mexico."

From the creators of the Vaccine:

"Sanofi Pasteur, the vaccines division of Sanofi, announced today that the Mexican authorities have granted marketing authorization to Dengvaxia^®, making it the first vaccine to be licensed in the world for the prevention of dengue."

"About Sanofi Pasteur's dengue vaccine

Sanofi Pasteur’s vaccine is the culmination of over two decades of scientific innovation and collaboration, as well as 25 clinical studies in 15 countries around the world. Over 40,000 volunteers participated in the Sanofi Pasteur dengue vaccine clinical study program (phase I, II and III), of whom, 29,000 volunteers received the vaccine. Dengvaxia^® successfully completed phase III clinical studies in 2014 to evaluate the primary objective of vaccine efficacy.^{7, 8}

^{http://www.sanofipasteur.com/en/articles/dengvaxia-world-s-first-dengue-vaccine-approved-in-mexico.aspx}

yeah Thailand, maybe in the next month or two you can get this Dengue vaccine thing wrapped up.